Gamma-aminobutyric acid type A and type B receptors (GABA-A/GABA-B)

Gamma-aminobutyric acid (GABA) receptors are the primary inhibitory neurotransmitter receptors in the central nervous system, categorized into two distinct classes: GABA-A and GABA-B (StatPearls, 2023). GABA-A receptors are pentameric ligand-gated ion channels that, upon activation, allow chloride ions to enter the neuron, leading to hyperpolarization and rapid inhibition of neuronal firing (UniProt, P14867). In contrast, GABA-B receptors are heterodimeric G protein-coupled receptors that mediate slower, more prolonged inhibitory signals by modulating potassium and calcium conductance through intracellular signaling cascades (UniProt, Q9UBS5). These receptors play a critical role in maintaining the excitatory-inhibitory balance in the brain, and their dysfunction is implicated in various neurological and psychiatric conditions, including epilepsy, anxiety, and sleep disorders (PubMed, PMC3055403). Pharmacological modulation of GABA-A receptors is widely used for sedation, anesthesia, and anxiolysis, while GABA-B receptors are primarily targeted for the treatment of spasticity and certain substance use disorders (NIH, PubChem).

Other names

GABA receptorsGamma-aminobutyric acid receptorsGABAR

GABA-A receptors function as ligand-gated chloride channels that mediate fast inhibitory postsynaptic potentials through positive allosteric modulation (e.g., benzodiazepines) or direct agonism (StatPearls, 2023). GABA-B receptors are G protein-coupled receptors that mediate slow, prolonged inhibitory effects by activating G protein-coupled inwardly rectifying potassium (GIRK) channels or inhibiting voltage-gated calcium channels via G-protein signaling (PubMed, PMC2824994).